SCHEMBL3522766

SCHEMBL3522766

[CH]OS(C)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4445189 0.67 USP2 (0.54)
SCHEMBL25600 0.67
Methanesulfonic Acid Methyl Ester SCHEMBL63290 0.67
Methanesulfonic Acid Methyl Ester SCHEMBL16060132 0.67 USP2 (1.00)
Methanesulfonic Acid Methyl Ester SCHEMBL573583 0.67
SCHEMBL5553793 0.65 ALDH1A1 (0.65)
SCHEMBL5830076 0.65 ALDH1A1 (0.65)
SCHEMBL1414701 0.65
SCHEMBL5452053 0.64
SCHEMBL179013 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2248806-A2 Quinazoline derivatives as tyrosine kinase inhibitors Shanghai Allist Pharmaceuticals, Inc. (CN) 2010-11-10 EP claimed
EP-2850062-B1 PYRIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CONDITIONS ASSOCIATED WITH PATHOLOGICAL THROMBUS FORMATION SANOFI SA (FR) 2017-07-19 EP disclosed
EP-2882715-B1 PYRAZOLE DERIVATIVES AND THEIR USE AS LPAR5 ANTAGONISTS SANOFI SA (FR) 2016-11-09 EP disclosed
US-9346762-B2 Pyrazole derivatives and their use as LPAR5 antagonists SANOFI (FR) 2016-05-24 US disclosed
US-9346757-B2 Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation SANOFI (FR) 2016-05-24 US disclosed
US-20150141471-A1 Pyridine Derivatives And Their Use In The Treatment Of Conditions Associated With Pathological Thrombus Formation SANOFI (FR) 2015-05-21 US disclosed
US-20150141477-A1 Pyrazole Derivatives And Their Use As LPAR5 Antagonists SANOFI (FR) 2015-05-21 US disclosed
EP-2850062-A1 PYRIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CONDITIONS ASSOCIATED WITH PATHOLOGICAL THROMBUS FORMATION SANOFI (FR) 2015-03-25 EP disclosed
WO-2013171316-A1 PYRIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CONDITIONS ASSOCIATED WITH PATHOLOGICAL THROMBUS FORMATION SANOFI (FR) 2013-11-21 WO disclosed